Results 261 to 270 of about 314,849 (336)

Discontinuation of the Clozapine Risk Evaluation and Mitigation Strategy and Implications in Movement Disorders

Movement Disorders Clinical Practice, EarlyView.
Charles Palmer, Alexander McClanahan, Federico Rodriguez‐Porcel   +2 more
wiley   +1 more source

Postmarketing Assessment of Antibody–Drug Conjugates: Proof‐of‐Concept Using Model‐Based Meta‐Analysis and a Clinical Utility Index Approach

CPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Antibody–drug conjugates (ADCs) are a promising class of targeted cancer therapies. However, they need careful dose optimization to maximize effectiveness and minimize side effects. Sometimes, safety issues may only become apparent after approval, so ongoing evaluation is important.
Innocent Gerald Asiimwe, Nour Chtiba, Samer Mouksassi, Goonaseelan (Colin) Pillai, Raimund M. Peter, Eunice Yuen, Venkatesh Pilla Reddy   +6 more
wiley   +1 more source

Correction to "First Report of MPL c.23T>G (p.M8R) Variant in Congenital Amegakaryocytic Thrombocytopenia: A Case Report". [PDF]

EJHaem
europepmc   +1 more source

Vaccine Induced Immune Thrombotic Thrombocytopenia After Sinopharm Vaccination: A Systematic Review of Case Reports. [PDF]

Clin Case Rep
Rehman S, Sukaina M, Aminpoor H, Davis S, Munir ABI, Karimi H.   +5 more
europepmc   +1 more source

Deep Brain Stimulation in a Child with Aicardi‐Goutières Syndrome‐7 (AGS7): A Case Report and Literature Review

Movement Disorders Clinical Practice, EarlyView.
Sangeetha Yoganathan, Siddharth Seth, Sunita Venkateswaran, Wei Kang Lim, Andrea LeBlanc‐Millar, Sara Breitbart, Vivek Pai, Asif Doja, Alfonso Fasano, George M. Ibrahim, Carolina Gorodetsky   +10 more
wiley   +1 more source

Population Pharmacokinetic Model of Pegbing in Healthy Subjects and Chronic Hepatitis B Patients

CPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Pegbing (peginterferon alpha‐2b) is a polyethylene glycol‐modified interferon α‐2b injection that has demonstrated favorable efficacy and safety profiles in the treatment of chronic hepatitis B (CHB). This study aimed to develop a population pharmacokinetic (PopPK) model of Pegbing in both healthy subjects and CHB patients and to investigate ...
Weizhe Jian, Yalin Yin, Rong Chen, Pingyao Luo, Tianyu Wang, Jianbo Gu, Zhengfang Du, Lei Cai, Tianyu Bao, Junsheng Xue, Ruoyi He, Tianyan Zhou   +11 more
wiley   +1 more source

Iguratimod alleviated Sjögren's syndrome through regulating macrophage polarization

Rheumatology &Autoimmunity, EarlyView.
Nonobese diabetic (NOD) mice exhibited characteristic of Sjögren's syndrome (SS), with increased M1 macrophages and deceased M2 macrophages. Iguratimod alleviated SS‐like symptoms and restored balance of macrophage polarization through inhibiting the mitogen‐activated protein kinases pathway in NOD mice.
Junqiao Guo, Yu Chen, Shumin Wang, Tingting Jiang, Yue Wang, Haolin Wu, Xiaojing Li, Genhong Yao   +7 more
wiley   +1 more source

REMISSION OF AMEGAKARYOCYTIC THROMBOCYTOPENIA INDUCED BY ANTILYMPHOCYTE GLOBULIN (ALG)

, 1986
R. Fäldt
openalex   +1 more source

Relapsing Chronic Immune Thrombocytopenia and Thrombosis: A Case Report. [PDF]

Cureus
Kose L.
europepmc   +1 more source

Heparin-Associated Thrombocytopenia

, 1986
Jeffrey S. Vender, E. B. Matthew, Irwin Silverman, H. Konowitz, Peter C. Dau   +4 more
openalex   +1 more source